Erik de Cabo

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Tomás José González‐López, Cristina Pascual, María Román et al. · American Journal of Hematology · 2014 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

Sara Alonso, Laura Magnano, Miguel Alcoceba et al. · British Journal of Haematology · 2017 · 80 citations · Full text

Medicine, Oncology, Pathology +15

Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia

José Ramón González‐Porras, Fernando Escalante, Emilia Pardal et al. · European Journal Of Haematology · 2013 · 62 citations

Medicine, Hematology, Surgery +13

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

Tomás José González‐López, Fernando Fernández‐Fuertes, José‐Ángel Hernández‐Rivas et al. · International Journal of Hematology · 2017 · 53 citations

Pharmacy, Pharmacology, Pharmacotherapy +3

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

Tomás José González‐López, María Román, Cristina Pascual et al. · European Journal Of Haematology · 2015 · 49 citations · Full text

Medicine, Hematology, Pharmacotherapy +10